Market Overview

UPDATE: Credit Suisse Upgrades GNC

Related GNC
GNC Says Cooperating With Federal Authorities With Respect to USP Labs Enforcement Actions
Dietary Supplement Stocks Getting Killed By DoJ, FDA's Forthcoming Press Conference
The Only Way to Invest in Moringa Mania (Small Cap Network)

In a note released Monday morning, Credit Suisse upgraded shares of GNC (NYSE: GNC) from Neutral to Outperform with a $43 price target.

The upgrade reflects three main factors, 1) the team at Credit Suisse is a fan of Mr. Archbold, who has both a record of success and experience in the space, 2) The market has "over penalized" GNC. The team believes that with some "tinkering" to certain fundamentals, the company's recent quarterly misses could be a different story and 3) The team is "intrigued" by a potential combination of GNC and Vitamin Shoppe, given the high degree of overlap and Archbold's knowledge of Vitamin Shoppe's strengths.

Latest Ratings for GNC

Nov 2015JP MorganMaintainsNeutral
Nov 2015BarclaysMaintainsOverweight
Oct 2015Stephens & Co.UpgradesEqual-weightOverweight

View More Analyst Ratings for GNC
View the Latest Analyst Ratings

Posted-In: Credit SuisseAnalyst Color Downgrades Price Target Analyst Ratings


Related Articles (VSI + GNC)

View Comments and Join the Discussion!

Get Benzinga's Newsletters